The primary function of the surfactant is to decrease the surface tension at the air–liquid interface in the alveoli and distal bronchioles, to promote lung expansion during inspiration and to prevent ...

Clinical characteristics of infants are summarized by frequencies for demographics and other categorical variables, and continuous variables are presented as median and range because data for many of ...

In a recent study posted to the bioRxiv* preprint server, researchers discuss the role of a surfactant-mediated inflammatory response employed by human lungs against the severe acute respiratory ...

Proceedings of the National Academy of Sciences of the United States of America, Vol. 114, No. 18 (May 2, 2017), pp. E3592-E3601 (11 pages) Casals C, Canadas O (2012) Role of lipid ordered/disordered ...

Researchers conducted a meta-analysis of 12 randomized controlled trials involving 2428 premature infants, comparing intratracheal budesonide plus pulmonary surfactant with pulmonary surfactant alone.

Alveoli are tiny, balloon-shaped air sacs located at the end of the bronchioles, the branch-like tubes in the lungs. The alveoli move oxygen and carbon dioxide (CO 2) molecules into and out of your ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Researchers observed immunoglobulin A autoantibodies ...

A nationwide study led by researchers at UCSF provides evidence that inhaled nitric oxide is safe and effective for the prevention of the most common type of long-term lung disease of very premature ...

A recently published preclinical study by researchers at Lawson Health Research Institute and Western University's Schulich School of Medicine & Dentistry, show that vaping may negatively affect ...

From the Cardiovascular Research Institute and the Department of Pediatrics, University of California Medical Center. Supported in part by a grant (HE-06285) from the United States Public Health ...

An engineer in California has an invention that she hopes will someday help people with damaged lungs breathe easier. Stanford University's Annelise Barron has developed a synthetic version of ...